What is Corti?
Corti is at the forefront of applying artificial intelligence within the healthcare sector. Its sophisticated software platform is designed to assist healthcare professionals during patient interactions by providing real-time support. The AI actively listens to consultations, automatically generating notes, accessing relevant databases, and cross-referencing patient symptoms with a vast repository of historical cases. This capability aims to ensure that each patient receives the most optimal and evidence-based treatment. Corti is recognized as a global leader in applied AI within healthcare and has garnered numerous industry accolades for its innovative solutions.
How much funding has Corti raised?
Corti has raised a total of $92M across 3 funding rounds:
Angel/Seed
$5M
Series A
$27M
Series B
$60M
Angel/Seed (2019): $5M, investors not publicly disclosed
Series A (2021): $27M led by Chr. Augustinus Fabrik, byFounders, Vaekstfonden, Hearcore, and Id Invest
Series B (2023): $60M supported by Atomico, Eurazeo, and EiFO
Key Investors in Corti
Atomico
Atomico is a European Venture Capital firm headquartered in London, with offices in Paris, Berlin and Stockholm. Its founder and CEO is Niklas Zennström, a serial entrepreneur who co-founded Skype and Kazaa.
Eurazeo
Headquartered in Paris and founded in 1969, Eurazeo is a leading global investment company with considerable private equity, venture capital, real estate, and private debt, Eurazeo acsupports companies of all sizes in their development by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
byFounders
byFounders VC is a community-powered early-stage venture fund that invests in globally ambitious teams connected to the Nordic and Baltic countries. The firm leverages a unique Collective of founders and operators to provide operational expertise and a global network to its portfolio companies.
What's next for Corti?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Corti. This capital infusion is expected to accelerate the company's product development, expand its market reach, and further solidify its position as a leader in AI-powered healthcare solutions. Corti is poised to leverage this financial backing to scale its operations, enhance its AI capabilities, and drive broader adoption of its platform, ultimately aiming to revolutionize how patient consultations are managed and documented globally.
See full Corti company page
